Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY

Diabetes Care. 2020 Jun;43(6):e65. doi: 10.2337/dc20-0012. Epub 2020 Apr 7.

Authors

David T Broome¹, Zehra Tekin², Kevin M Pantalone², Adi E Mehta²

Affiliations

¹ Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH broomed@ccf.org.
² Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH.

No abstract available

Publication types

Letter